U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG Sec 515.425 Sugar - Water Damaged - Reconditioning
  1. Search for FDA Guidance Documents

COMPLIANCE POLICY GUIDE (CPG)

CPG Sec 515.425 Sugar - Water Damaged - Reconditioning March 1995

Final
Issued by:
Guidance Issuing Office
Office of Inspections and Investigations
Human Foods Program

BACKGROUND:

The Center for Food Safety and Applied Nutrition has agreed to the following refining process for reconditioning water damaged sugar:

  1. Introduce sugar into refining process at site of high raw sugar melter or "high remelt" melter.
  2. Determine if sugar condition warrants lime, P205, etc. treatment.
  3. Mix with water or process juices to a 65-70 percent concentration.
  4. Maintain temperature at 95oC (203oF) or greater.
  5. Add filter aid or diatomaceous earth and pass process sirup through clarifiers or pressure filters and continue through char, *carbon, and/or ion exchange resin* filters to improve color.
  6. Introduce filtered liquors into vacuum pans and boil to point of supersaturation.
  7. Introduce seed crystals and continue crystal growth to optimum size.
  8. Centrifuge, wash with hot water, and dry in granulator.
  9. Place in bulk refined storage or screen to desired commercial product size.
  10. The supernate and centrifugal washings are returned to normal process stream.

POLICY:

The above method is suitable for reconditioning sugar damaged by non-potable fresh or salt water.

NOTE: The method is not suitable for reconditioning sugar if there is evidence that the sugar was damaged by chemicals or sewage (floods, flooded ship's toilet, etc.).

*Material between asterisks is new or revised.*

Issued: 10/1/80
Revised: 3/95

Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.

Back to Top